FDA Commissioner Marty Makary told Fox News last month that the data from Pfizer’s recently completed Phase 3 clinical trial showed that adults 65 and older were at higher risk of several serious adverse events, including kidney failure and acute respiratory failure. “We’re not just going to rubber-stamp new products that don’t work, that fail in a clinical trial,” Makary said.

https://childrenshealthdefense.org/defender/fda-makary-wont-approve-pfizer-mrna-flu-vaccine-without-better-safety-data/?